Anti-CD4 antibody homologs useful in prophylaxis and treatment of AIDS, ARC and HIV infection
US5871732A · kind A · utility
19Cited by
7References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 27, 1991 |
| Grant date | Feb 16, 1999 |
| Priority date | — |
| Expiry date | Nov 27, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-CD4 antibody homologs, DNA sequences and recombinant DNA molecules encoding them, prophylactic, immunotherapeutic and diagnostic compositions comprising those antibody homologs, and methods for preventing or treating diseases in mammals, including humans, caused by infective agents whose primary targets are CD4.sup.+ lymphocytes. Such diseases include acquired immune deficiency syndrome ("AIDS"), AIDS related complex, and human immunodeficiency virus infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.